...
首页> 外文期刊>BMC Anesthesiology >Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study
【24h】

Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study

机译:无阿片类药物麻醉对心脏手术术后期的影响:一项回顾性病例对照研究

获取原文
           

摘要

No study has been conducted to demonstrate the feasibility of an opioid-free anesthesia (OFA) protocol in cardiac surgery to improve patient care. The aim of the present study was to evaluate the effect of OFA on post-operative morphine consumption and the post-operative course. After retrospectively registering to clinicaltrial.gov (NCT03816592), we performed a retrospective matched cohort study (1:1) on cardiac surgery patients with cardiopulmonary bypass between 2018 and 2019. Patients were divided into two groups: OFA (lidocaine, dexamethasone and ketamine) or opioid anaesthesia (OA) (sufentanil). The main outcome was the total postoperative morphine consumption in the 48?h after surgery. Secondary outcomes were rescue analgesic use, a major adverse event composite endpoint, and ICU and hospital length of stay (LOS). One hundred ten patients were matched (OFA: n?=?55; OA: n?=?55). On inclusion, demographic and surgical data for the OFA and OA groups were comparable. The total morphine consumption was higher in the OA group than in the OFA group (15 (6–34) vs 5?mg (2–18), p?=?0.001). The pain score during the first 48 post-operative hours did not differ between the two groups. Creatinine values did not differ on the first post-operative day (80 (IQR: 66–115) vs 77?mmol/l (IQR: 69–95), p?=?0.284). Incidence of the composite endpoint was lower in the OFA group (25 patients (43%) vs 38 patients (68%), p?=?0.021). The time to extubation and the ICU stays were shorter in the OFA group (3 (1–5) vs 5 (3–6) hours, p?=?0.001 and 2 (1–3) vs 3 (2–5) days, p?=?0.037). The use of OFA was associated with lower morphine consumption. OFA might be associated with shorter intubation time and ICU stays. Further randomized studies are needed to confirm these results. This study was retrospectively registered to ct2 (identifier: NCT03816592 ) on January 25, 2019.
机译:尚无研究证明无阿片类药物麻醉(OFA)方案在心脏外科手术中改善患者护理的可行性。本研究的目的是评估OFA对术后吗啡消耗和术后病程的影响。在向临床试验.gov(NCT03816592)进行回顾性注册后,我们对2018年至2019年之间进行心脏搭桥手术的心脏外科手术患者进行了一项回顾性配对队列研究(1:1)。患者分为两组:OFA(利多卡因,地塞米松和氯胺酮)或阿片类药物麻醉(OA)(舒芬太尼)。主要结局是术后48小时内术后吗啡的总消耗量。次要结果是抢救性镇痛药的使用,主要不良事件复合终点,ICU和住院时间(LOS)。匹配了一百零一例患者(OFA:n =?55; OA:n?=?55)。在纳入方面,OFA和OA组的人口统计学和外科手术数据具有可比性。 OA组的总吗啡消耗量高于OFA组(15(6-34)vs 5?mg(2-18),p?=?0.001)。两组在术后48小时内的疼痛评分没有差异。术后第一天的肌酐值没有变化(80(IQR:66–115)vs 77?mmol / l(IQR:69–95),p?=?0.284)。在OFA组中,复合终点的发生率较低(25例(43%)比38例(68%),p == 0.021)。 OFA组的拔管时间和ICU停留时间较短(3(1-5)vs 5(3-6)小时,p?=?0.001,2(1-3)vs 3(2-5)天,p≤0.037)。使用OFA与降低吗啡消费量有关。 OFA可能与较短的插管时间和ICU停留时间有关。需要进一步的随机研究以证实这些结果。这项研究已于2019年1月25日追溯注册至ct2(标识符:NCT03816592)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号